Why Catapult Group International Ltd is one stock to watch

One tiny Aussie company is taking on the world in sports analytics. Can it win?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You may have noticed AFL, rugby union and rugby league players wearing what look like bras, with a special pocket in the middle of their back.

No, it's not a new fashion statement, but a recent trend in sports analytics, with players wearing hardware devices to monitor and track their performance on the field.

Catapult Group International Ltd (ASX: CAT) is the company providing those devices as well as the sophisticated analytical software, which can be used to analyse the data gathered by the device.

A recent listing on the ASX, Catapult has a huge range of clients, including all AFL teams, all NRL teams every Super Rugby team, Australia's cricketers, Wallabies and Socceroos, not to mention the Australian Institute of Sport – and that's just in Australia.

Overseas, Catapult products are used by 12 US National Football League (NFL) teams, 10 US National Basketball Association (NBA) teams, 10 British soccer teams and more than 30 other premier teams competing in European competitions. In fact, 70% of revenues come from offshore. The funds raised in the IPO will be used to continue the company's expansion into North America and Europe in particular.

Two of the company's founders still work full time in the business, and hold a significant amount of shares after the IPO. Growth is expected to come from increased market penetration, continued subscription sales, recurring revenue, product upgrades and new analytical packages, and expansion into new markets such as military/defence and consumer devices.

Could this company, with its technology purchased from the Commonwealth Co-operative Research Centre (CRC) and its numerous patents be another CSL Limited (ASX: CSL)? By the way, did you know that CSL started out as Commonwealth Serum Laboratories, before being privatised in 1994 – hence the CSL.

Potentially it could be yes. But at this stage it's still a risky proposition and the company has yet to produce a profit. It's unlikely to pay a dividend either in its early days – with the company noting in its prospectus that it believes cash would be better served by being reinvested back into the company. If the company can generate high returns on equity – then logically, it should reinvest the cash back into the business.

Add this one to your watchlist.

Motley Fool writer/analyst Mike King owns shares in CSL Limited. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »